Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Pediatrix Medical (MD) Interest Expenses (2016 - 2025)

Historic Interest Expenses for Pediatrix Medical (MD) over the last 17 years, with Q3 2025 value amounting to $8.9 million.

  • Pediatrix Medical's Interest Expenses fell 1170.25% to $8.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $36.9 million, marking a year-over-year decrease of 1016.44%. This contributed to the annual value of $40.7 million for FY2024, which is 316.58% down from last year.
  • According to the latest figures from Q3 2025, Pediatrix Medical's Interest Expenses is $8.9 million, which was down 1170.25% from $9.1 million recorded in Q2 2025.
  • In the past 5 years, Pediatrix Medical's Interest Expenses ranged from a high of $17.6 million in Q1 2021 and a low of $8.4 million during Q2 2022
  • For the 5-year period, Pediatrix Medical's Interest Expenses averaged around $11.5 million, with its median value being $10.3 million (2024).
  • Its Interest Expenses has fluctuated over the past 5 years, first tumbled by 5018.07% in 2022, then soared by 3354.74% in 2023.
  • Quarter analysis of 5 years shows Pediatrix Medical's Interest Expenses stood at $16.6 million in 2021, then tumbled by 40.06% to $10.0 million in 2022, then rose by 1.3% to $10.1 million in 2023, then decreased by 3.68% to $9.7 million in 2024, then decreased by 7.92% to $8.9 million in 2025.
  • Its Interest Expenses stands at $8.9 million for Q3 2025, versus $9.1 million for Q2 2025 and $9.2 million for Q1 2025.